# Cellectar Biosciences, Inc.: Form DEF 14A, filed Oct 2, 2023

- Company: [Cellectar Biosciences, Inc.](/companies/clrb.md) (CIK 1279704)
- Form: DEF 14A
- Filed: 2023-10-02
- Accepted by EDGAR: Oct 2, 2023, 16:40 ET
- Period: 2023-10-25
- Accession: 0001104659-23-105926
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1279704/000110465923105926/tm2326633d2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1279704/000110465923105926/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1279704/000110465923105926/tm2326633d2_def14a.htm

Filed Oct 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-105926. Last ingested by Listed: Nov 10, 2026, 16:55 ET. No prices; not investment advice.
